MSN Laboratories Private Limited — Carmustine Exporter Profile
Indian Pharmaceutical Exporter · #2 for Carmustine · $850.0K export value · DGFT Verified
MSN Laboratories Private Limited is the #2 Indian exporter of Carmustine with $850.0K in export value and 17 verified shipments. MSN Laboratories Private Limited holds a 3.8% market share in Carmustine exports across 4 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Carmustine Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Carmustine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $303.3K | 9 | 69.2% |
| MALTA | $114.3K | 6 | 26.1% |
| UNITED STATES | $20.4K | 1 | 4.7% |
| SWEDEN | $97 | 1 | 0.0% |
MSN Laboratories Private Limited exports Carmustine to 4 countries. The largest destination is CANADA accounting for 69.2% of MSN Laboratories Private Limited's Carmustine shipments, followed by MALTA (26.1%) and UNITED STATES (4.7%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Carmustine from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STERIMAX INC | CANADA | $253.0K | 7 |
| PHARMADOX HEALTHCARE LTD | MALTA | $64.0K | 2 |
| TO THE ORDER OF | CANADA | $50.0K | 1 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $50.0K | 1 |
| NOVADOZ PHARMACEUTICALS LLC | UNITED STATES | $20.4K | 1 |
| PHARMADOX HEALTHCARE LTD., | MALTA | $241 | 3 |
| STERIMAX INC. | CANADA | $232 | 1 |
| SWEDISH MEDICAL PRODUCTS AGENCY LAKEMEDELSVERKET DAG HAMMARSKJOLDSVAG | SWEDEN | $97 | 1 |
MSN Laboratories Private Limited supplies Carmustine to 8 buyers globally. The largest buyer is STERIMAX INC (CANADA), followed by PHARMADOX HEALTHCARE LTD (MALTA) and TO THE ORDER OF (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Carmustine Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $6.5M worth of Carmustine through 340 shipments from 50 suppliers to 54 countries, serving 135 buyers globally. MSN Laboratories Private Limited contributes $850.0K to this total, accounting for 3.8% of India's Carmustine exports. MSN Laboratories Private Limited ships Carmustine to 4 countries through 8 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Carmustine Exports?
MSN Laboratories Private Limited's average Carmustine shipment value is $50.0K per consignment, based on 17 shipments totaling $850.0K. The largest destination is CANADA (69.2% of MSN Laboratories Private Limited's Carmustine exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Carmustine Exporters?
MSN Laboratories Private Limited ranks #2 among 50 Indian Carmustine exporters with a 3.8% market share. The top 3 exporters are EMCURE PHARMACEUTICALS LIMITED ($4.0M), MSN LABORATORIES PRIVATE LIMITED ($850.0K), INTAS PHARMACEUTICALS LIMITED ($778.2K). MSN Laboratories Private Limited processed 17 shipments to 4 destination countries.
What Carmustine Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CARMUSTINE FOR INJECTION USP 100 MG (900PAC) | $100.0K | 2 |
| MSN PHARMA CARMUSTINE FOR INJECTION USP100 MG | $50.0K | 1 |
| CARMUSTINE FOR INJECTION USP 100 MG (350PAC) | $50.0K | 1 |
| CARMUSTINE FOR INJECTION USP 100 MG (900PAC)900NOS550 | $50.0K | 1 |
| CARMUSTINE FOR INJECTION USP 100 MG (350PAC)350NOS550 | $50.0K | 1 |
| CARMUSTINE 100MG VIAL ES (SENDING ALONGWITH 200 NOS AS FREE SAMPLE) | $50.0K | 1 |
| CARMUSTINE 100MG VIAL DE (SENDING ALONGWITH 180 NOS AS FREE SAMPLE) | $45.3K | 1 |
| CARMUSTINE INJECTION 100 MG/VIAL 1S | $20.4K | 1 |
| CARMUSTINE 100MG VIAL ES-809245 (SENDINGALONG WITH 179 NOS AS FREE SAMPLE) | $18.8K | 1 |
| CARMUSTINE DILUENT VIAL (61 PAC) | $1.5K | 1 |
MSN Laboratories Private Limited exports 16 distinct Carmustine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CARMUSTINE FOR INJECTION USP 100 MG (900PAC) with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Carmustine to Key Markets
What MSN Laboratories Private Limited must comply with to export Carmustine to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Carmustine Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED | $4.0M | 81 | 19 | $50.0K |
| 2 | MSN LABORATORIES PRIVATE LIMITED ★ | $850.0K | 17 | 4 | $50.0K |
| 3 | INTAS PHARMACEUTICALS LIMITED | $778.2K | 44 | 6 | $17.7K |
| 4 | THERDOSE PHARMA PRIVATE LIMITED | $455.2K | 22 | 8 | $20.7K |
MSN Laboratories Private Limited ranks #2 among 50 Indian Carmustine exporters. Average shipment value of $50.0K compared to the market average of $129.7K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Carmustine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 67 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 45 | 13.2% |
| HYDERABAD AIR | 38 | 11.2% |
| HYDERABAD ACC (INHYD4) | 28 | 8.2% |
| AHEMDABAD AIR ACC (INAMD4) | 23 | 6.8% |
| Bombay Air | 18 | 5.3% |
| DELHI AIR | 15 | 4.4% |
| AHEMDABAD AIR | 11 | 3.2% |
What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Carmustine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Carmustine, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carmustine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carmustine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 17 individual customs records matching MSN Laboratories Private Limited exporting Carmustine, covering 16 formulations to 4 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 54+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carmustine Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Carmustine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Carmustine Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carmustine. For current shipment-level data, contact TransData Nexus.